AI Demand Generation for Medical Devices & MedTech

The Demand Generation challenge for Medical Devices & MedTech

Medical device marketing that drives adoption requires simultaneous execution on three tracks: clinical evidence (peer-reviewed publications, society presentation abstracts, clinical registry participation), economic justification (published health economic analyses, cost-per-procedure comparisons, length-of-stay impact), and reimbursement support (CPT code coverage, coverage determination letters, payer medical policies). Skipping any track creates a sales ceiling that no campaign can overcome. Sunshine Act-compliant KOL relationship management — where physician education funding and speaking fees are properly documented and reported — is both a compliance requirement and a marketing asset: disclosed, transparent relationships with recognized clinical experts build more credibility than undisclosed ones.

On Demand Generation specifically, Medical Devices & MedTech teams run into: Hospital value analysis committee (VAC) reviews are the primary purchase gate for capital equipment and novel devices — a device that has clinical champion support but fails economic justification (no published cost-effectiveness data, no reimbursement code, no comparable reduction in length of stay) does not get approved; GPO (Group Purchasing Organization) contract coverage is prerequisite for reaching most US hospital systems at scale — marketing to hospitals not on your GPO contract generates clinical interest that procurement can't fulfill, wasting sales resources on unconvertible prospects; FDA clearance and approval claims require extraordinary precision — marketing materials must use only cleared indications, cannot imply off-label use, and must include required device labeling language even in digital ad formats where character limits are real; Clinical evidence generation is a long-cycle investment (3–7 years for RCT evidence) that competes with short-cycle commercial pressure — medtech companies that don't invest in evidence early face a permanent credibility ceiling against competitors who did; Physician preference and KOL endorsement drive adoption in surgical and interventional specialties, but KOL relationships are subject to Sunshine Act reporting requirements that create compliance exposure if not managed correctly. FDA 21 CFR Part 807 (510(k) clearance process); FDA 21 CFR Part 814 (PMA process for Class III devices); FDA Off-Label Promotion prohibition (device labeling and promotion must match cleared indications); Physician Payments Sunshine Act (Open Payments) reporting for physician KOL relationships; Anti-Kickback Statute implications for device incentives; HIPAA for any patient data used in clinical studies; EU MDR (Medical Device Regulation) and IVDR for European device marketing; ISO 13485 quality system certification as marketing credibility signal; GDPR for clinical study and registry data involving EU patients

How Hadrian's Demand Generation Agent runs Demand Generation for Medical Devices & MedTech

AI scores and routes every inbound lead in seconds and monitors intent signals across thousands of accounts — no human SDR team can match that coverage and speed. The agent reads Marketing automation platform (HubSpot / Marketo — lead records, form fills, campaign membership), Intent data feeds (Bombora, G2 Buyer Intent, 6sense), CRM pipeline (MQL-to-SQL conversion rates, sales rep capacity), Event platform data (attendance, session engagement, Q&A activity) and runs: Orchestrate integrated demand campaigns across paid, content, email, and events with a unified theme; Score inbound leads in real time using firmographic, behavioral, and intent data signals; Route MQLs to the correct sales rep or nurture track based on ICP fit score and segment; Manage the webinar and virtual event calendar: invites, reminders, follow-up sequences; Operate the lead-to-MQL funnel report and flag volume drops by source and segment; Run account intent monitoring (Bombora / G2 Buyer Intent) and surface warm accounts to sales — applied to Medical Devices & MedTech context.

For Medical Devices & MedTech that means coordinated execution across Clinical specialty society conferences (ACC, ASN, AAOS, AANS, SAGES, DDW — by clinical specialty), Medical device trade publications (MedCity News, MassDevice, Fierce Medtech, Medical Design & Outsourcing), LinkedIn (CMO or Chief Medical Officer at health systems, OR/cath lab directors, surgeon KOLs, Hospital Value Analysis Coordinator), GPO marketing programs (Vizient, Premier, HealthTrust preferred vendor marketing channels), Clinical society exhibit halls and physician education programs (CME-supported symposia around major meetings) without adding headcount, with a human approval gate before anything publishes or spends.

What you get

Outputs: MQL volume report (by source, segment, and ICP tier — weekly), Lead routing queue (scored, segmented, routed to sales or nurture), Campaign performance report (by theme and channel contribution), Intent account shortlist (weekly — accounts showing in-market signals) — tuned to Medical Devices & MedTech buyers (VP Marketing or VP Commercial at a medical device manufacturer (Series C through public); Product Manager responsible for a specific device line; VP Sales or National Accounts Director managing GPO relationships and IDN accounts; at health systems, a Value Analysis Coordinator or Director of Supply Chain evaluating device portfolios; Interventional Cardiologist, Orthopedic Surgeon, or specialty physician as clinical evaluator and champion) and moving MQL volume (per month, by channel), MQL-to-SQL conversion rate, Demand-gen attributed pipeline ($). The Demand Generation Agent works alongside Hadrian's other agents so Demand Generation stays aligned with the rest of your marketing.

RELATED